Literature DB >> 12589875

Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark.

Henrik Toft Sørensen1, Ane Marie Thulstrup, Lene Mellemkjar, Peter Jepsen, Erik Christensen, Jørgen H Olsen, Hendrik Vilstrup.   

Abstract

Mortality from cirrhosis of the liver has been examined in few long-term follow-up studies. In the Danish National Registry of Patients, 1982-1989, we identified a cohort of 10,154 patients with liver cirrhosis and divided them according to the etiology of their liver disease. Causes of death were identified in the Danish Death Registry, 1982-1993. We estimated relative survival and standardized mortality ratios by comparing with the mortality in the general population. The 10-year relative survival was worse in patients with alcoholic cirrhosis (34%) or nonspecified cirrhosis (32%) than in patients with primary biliary cirrhosis (58%) or chronic hepatitis (66%). The standardized mortality ratio for all causes of death combined was 12-fold increased, 5-fold excluding cirrhosis-related causes. Mortality in all disease categories was increased, even in those not traditionally related to cirrhosis. In conclusion, patients with cirrhosis of the liver face reduced life expectancy due to several causes of death.

Entities:  

Mesh:

Year:  2003        PMID: 12589875     DOI: 10.1016/s0895-4356(02)00531-0

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  41 in total

1.  Hospitalization for complications of cirrhosis: does volume matter?

Authors:  Anand Singla; James L Hart; Youfu Li; Jennifer F Tseng; Shimul A Shah
Journal:  J Gastrointest Surg       Date:  2010-11-25       Impact factor: 3.452

Review 2.  Mortality from cirrhosis: lack of progress over the last 35 years.

Authors:  C Gluud
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

3.  Years of life lost in the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong.

Authors:  Ying Zhou; Eric H Y Lau; Dennis K M Ip; Hiroshi Nishiura; Gabriel M Leung; Wing-Hong Seto; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2013-08-26       Impact factor: 4.897

4.  Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?

Authors:  Karen V Danielsen; Signe Wiese; Jens Hove; Flemming Bendtsen; Søren Møller
Journal:  Dig Dis Sci       Date:  2018-03-08       Impact factor: 3.199

Review 5.  Statin therapy in patients with cirrhosis.

Authors:  Andrew P Wright; Srinath Adusumalli; Kathleen E Corey
Journal:  Frontline Gastroenterol       Date:  2014-08-08

6.  Pulmonary resection for non-small cell lung cancer in patients with hepatocellular carcinoma.

Authors:  Takashi Iwata; Noritoshi Nishiyama; Koshi Nagano; Nobuhiro Izumi; Shinjiro Mizuguchi; Ryuhei Morita; Takuma Tsukioka; Shoji Hanada; Kiyotoshi Inoue; Shoji Kubo; Shigekazu Takemura; Shigefumi Suehiro
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

7.  The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study.

Authors:  Peter Jepsen; Hendrik Vilstrup; Peter Ott; Susanne Keiding; Per K Andersen; Niels Tygstrup
Journal:  BMC Gastroenterol       Date:  2009-06-30       Impact factor: 3.067

Review 8.  Liver surgery in cirrhosis and portal hypertension.

Authors:  Christina Hackl; Hans J Schlitt; Philipp Renner; Sven A Lang
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

Review 9.  Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.

Authors:  Wen-Lung Ma; Hsueh-Chou Lai; Shuyuan Yeh; Xiujun Cai; Chawnshang Chang
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

Review 10.  Targeting collagen for diagnostic imaging and therapeutic delivery.

Authors:  Hendra Wahyudi; Amanda A Reynolds; Yang Li; Shawn C Owen; S Michael Yu
Journal:  J Control Release       Date:  2016-01-07       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.